In Vitro Activity of Dalbavancin against Refractory Multidrug-Resistant (MDR) Staphylococcus aureus Isolates

The high prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infections, always treated with vancomycin and daptomycin, has led to the emergence of vancomycin-intermediate (VISA), heteroresistant vancomycin-intermediate (hVISA) and daptomycin non-susceptible (DNS) S. aureus. Even if gly...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antibiotics (Basel)
Autors principals: Bongiorno, Dafne, Lazzaro, Lorenzo Mattia, Stefani, Stefania, Campanile, Floriana
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7761838/
https://ncbi.nlm.nih.gov/pubmed/33287376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics9120865
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars